Navigation Links
Global Biomarkers Technologies, Markets and Companies Report 2017-2025: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics - Research and Markets
Date:2/1/2017

DUBLIN, Feb 1, 2017 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biomarkers - Technologies, Markets and Companies" to their offering.

This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century.

Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics.

Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine.

Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed.

Biomarker markets are estimated from 2015 to 2025 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed.

A large number of companies with varying technical backgrounds are involved in biomarkers and 302 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 463 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 1,200 references, 76 tables and 18 figures.

Key Topics Covered:

Part 1: Technologies & Markets 

Executive Summary

1. Introduction

2. Technologies for Discovery of Biomarkers

3. Biomarkers and Molecular Diagnostics

4. Biomarkers for Drug Discovery & Development

5. Role of Biomarkers in Healthcare

6. Biomarkers of Cancer

7. Biomarkers of Disorders of the Nervous System

8. Biomarkers of Cardiovascular Disorders

9. Biomarkers & Personalized Medicine

10. Biomarkers and Regulatory issues

11. Markets for Biomarkers

12. References

Part II: Companies

13. Companies

For more information about this report visit http://www.researchandmarkets.com/research/jdfj6m/biomarkers

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-biomarkers-technologies-markets-and-companies-report-2017-2025-proteomics-metabolomics-molecular-diagnostics-drug-discovery-clinical-trials-and-bioinformatics---research-and-markets-300400460.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Global Regulatory Milestones for Invibio Biomaterial Solutions
4. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
5. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
6. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
7. Global Biochips and Microarrays 2013 Market Report
8. Global Bio-implants Market 2012-2016 New Research Report Now Available at MarketResearchReports.biz
9. USP Global Fellowship Awards Program Call for Applications
10. Medical Gases and Equipment Market is Expected to Reach USD 9 Billion Globally in 2018: Transparency Market Research
11. Global Food Safety Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2019)... , ... March 14, 2019 , ... The growth in ... for companies to keep up. Traditional Regulatory intelligence (RI) systems ... technology to get global Regulatory teams right Insights faster and cheaper. With a diversity ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON NOVEMBER 27, 2018, Nova ... Eye Machine Canada Inc., had been given approval to begin a clinical patient ... Degeneration (AMD). , The previous month, the medical devices bureau of Health Canada ...
(Date:3/14/2019)... ... March 13, 2019 , ... ... ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium on 25–26 September ... technical and operational solutions, and innovative approaches. , “Biopharmaceuticals have become a ...
(Date:3/12/2019)... ... 11, 2019 , ... Centura Health, the region’s health care ... in the nation, to offer needle-free blood draws for inpatients. , Littleton Adventist ... which staff showed compassion jumped up by an average of 15.4% during the ...
Breaking Biology Technology:
(Date:2/27/2019)... ... , ... Circulomics is launching the Short Read Eliminator Kit to ... preparation. , This kit enhances long-read sequencing read lengths by using size selective ... damaged and recovered with high efficiency. Short DNA up to 25 kb in length ...
(Date:2/22/2019)... , ... February 21, 2019 , ... Clean label food ... expected when creating natural foods and beverages. It is quite common to spot consumers ... Yet, meat products are not immune to this label scrutiny. , More than ...
(Date:2/19/2019)... ... February 20, 2019 , ... ... out across the organization. Dimensions provides in-depth data, visualizations, and analytics to ... planning, and understand past and future funding activity. , Developed in collaboration ...
Breaking Biology News(10 mins):